ALKS vs CSX · P/E 14, rev $1.56B vs P/E 19, rev $14.09B
Alkermes Plc (ALKS) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
CSX Corporation (CSX) is a railroads company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the ALKS and CSX stock pages for the full models.
Not investment advice.